HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 96 filers reported holding HARVARD BIOSCIENCE INC in Q3 2023. The put-call ratio across all filers is 0.56 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,030,879 | -16.6% | 3,262,995 | +6.5% | 5.58% | -9.7% |
| Q2 2023 | $16,815,667 | +17.5% | 3,062,963 | -10.1% | 6.18% | +4.2% |
| Q1 2023 | $14,316,943 | +62.2% | 3,408,796 | +6.9% | 5.93% | +49.9% |
| Q4 2022 | $8,828,810 | +101.1% | 3,187,296 | +85.8% | 3.95% | +67.5% |
| Q3 2022 | $4,391,000 | -21.0% | 1,715,235 | +11.0% | 2.36% | -11.1% |
| Q2 2022 | $5,561,000 | -0.3% | 1,544,647 | +71.9% | 2.66% | -0.4% |
| Q1 2022 | $5,579,000 | +30.5% | 898,436 | +48.2% | 2.67% | +29.7% |
| Q4 2021 | $4,275,000 | – | 606,394 | – | 2.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AMH Equity Ltd | 2,000,000 | $10,980,000 | 12.55% |
| 272 Capital LP | 3,062,963 | $16,815,667 | 6.18% |
| Meros Investment Management, LP | 813,014 | $4,463,447 | 2.21% |
| Harvey Partners, LLC | 2,524,000 | $13,856,760 | 1.70% |
| PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 2,862,649 | $15,715,943 | 0.96% |
| BARD ASSOCIATES INC | 286,922 | $1,575,202 | 0.61% |
| Acuitas Investments, LLC | 180,300 | $989,847 | 0.58% |
| Portolan Capital Management | 783,591 | $4,301,915 | 0.38% |
| Archon Capital Management LLC | 279,358 | $1,533,675 | 0.32% |
| HEARTLAND ADVISORS INC | 850,000 | $4,666,500 | 0.27% |